Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

15 May 2014 07:00

RNS Number : 1476H
Tarsus Group PLC
15 May 2014
 



15 May 2014

 

TARSUS GROUP plc

 

Interim Management Statement

 

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, is today publishing its Interim Management Statement for the period from 1 January 2014 to 14 May 2014.

 

Overview

 

We continue to concentrate on the execution of our "Quickening the Pace" strategy, focusing on accelerating financial returns to shareholders. This is being achieved by investing in and strengthening our core businesses, in particular driving organic growth and adding value to our key brands through replication into faster growth economies and identifying selective small strategic acquisitions. We have made good progress in integrating our recent acquisitions.

 

Revenues for the year ending 31 December 2014 are heavily weighted towards the second half of the year owing to the timing of exhibitions. Trading for the smallest period in our two year cycle remains in line with the Board's expectations.

 

Forward bookings for the year to 31 December 2014 are tracking 9% ahead of last year (as adjusted for biennial events and acquisitions) and the Group remains confident of delivering a good performance in 2014 on a constant currency basis.

 

Emerging markets

 

The Group's emerging markets businesses continue to gain momentum through a combination of organic growth, including replications, and the successful integration of recent acquisitions.

 

Our Dubai division is enjoying good trading and the GESS (education) show in March 2014 produced a particularly strong performance. The outlook for MEBA (business aviation) in November 2014 is very positive.

 

Trading in Turkey was in line with our cautious expectations. The performance of the largest event held in the period, Ideal Homex (April 2014), was ahead of last year. Forward bookings are good and continue to improve for the larger events, Zuchex, Sign and the Flower Show.

 

In Mexico, the Group's Joint Venture with EJ Krause got off to a strong start in March 2014 with the first event Expo Manufactura, Mexico's premier metalworking/manufacturing exhibition, performing ahead of plan at the time of acquisition. We are optimistic about the outlook for Plastimagen in November 2014. As part of our "Quickening the Pace" strategy the Joint Venture plans to launch three further shows in 2015.

 

In China, Hope is performing well and ahead of the same period last year. In early 2014, the Group purchased SIUF, Asia's leading underwear show and the first event under Tarsus' ownership took place last week in Shenzhen. The exhibition performed strongly and in accordance with our investment case. As previously reported GZ Auto, held in January, was behind the previous edition.

 

US

 

In early 2014, the Group broadened its medical education offering with the launch of the Medical Metabolic Institute (MMI), the first event for which is scheduled for June 2014. As anticipated existing educational revenue streams were weaker ahead of the MMI launch. The first major medical event of the year in Orlando opens today and a record edition is expected.

 

The integration of the recent Cardiometabolic Health Congress acquisition is progressing well and the outlook for the October 2014 show corresponds with management's expectations at the time of acquisition.

 

The February 2014 Off-Price event in Las Vegas produced a solid performance, with good visitor growth. Bookings for the August 2014 Off-Price event in Las Vegas are tracking ahead of the 2013 edition.

 

Labelexpo America, the Group's largest US event taking place in September 2014, is benefiting from improving economic conditions and a record edition is expected.

 

Europe

 

The French portfolio is performing slightly ahead of 2013. With the largest exhibitions taking place in the second half of the year, the Group's projections for its French business remains cautious for the full year.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Annual Results on 4 March 2014.

 

Douglas Emslie, Tarsus Group Managing Director, said:

 

"We have made a promising start to trading in 2014 and the economic background in most of our markets is encouraging. Bookings for the balance of the year are in line with our expectations.

 

"We continue to drive organic growth from the business as a whole and in particular from our major brands. Our programme of replicating our leading events into growth markets is gaining momentum."

 

The Group expects to publish its interim results for the six months ending 30 June 2014 on 30 July 2014.

 

For further information:

Tarsus Group plc:

Douglas Emslie, Group Managing Director

020 8846 2700

Dan O'Brien, Group Finance Director

 

Neville Harris

07909 976044

 

Notes to editors

 

Tarsus Group plc (LSE:TRS) is an international business-to-business media group with interests in exhibitions, publishing and online media. The Group operates globally in key verticals including aviation, medical, labels and packaging, discount clothing (Off-Price), housewares and automotive. Tarsus runs more than 80 events and websites and its flagship brands include the Labelexpo exhibitions in Europe, the Americas, India and Asia and the Dubai Airshow.

 

The Group operates across a worldwide network of offices in Dublin, London, Paris, Milwaukee, Boca Raton (Florida), Dubai, Shanghai, Jakarta, New Delhi and Istanbul. Tarsus is building on its strong presence in the emerging markets of the Middle East, China, Turkey, Indonesia and Mexico.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQKQDBABKDOPD
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBlock Listing Six Monthly Return
9th May 20187:00 amRNSBoard Changes
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.